|
|
Article: Cantab Pharmaceuticals Reports Second Quarter Results
- Article from:
- PR Newswire
- Article date:
- August 12, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, England, Aug. 12 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY) today announced financial results for the second quarter ended June 30, 1996.
Revenues for the second quarter of 1996 were 8,000 pounds sterling, compared to 35,000 pounds for the same period in 1995. Revenues for the first six months of 1996 were 25,000 pounds, compared to 170,000 pounds for 1994. In 1996, revenues comprised contract development fees earned under Cantab's current collaborative agreement with Pfizer Animal Health Group in 1996, and in 1995, revenues comprised contract development fees earned under Cantab's collaborative agreement with Baxter Healthcare ...
Related newspaper, magazine, and journal articles:
|
|
Article: MOBESTAR HOLDINGS PLC - Correction : Half-yearly ...
PR Newswire UK Disclose;
October 8, 2007 ;
700+ words
... ... unaudited) (unaudited) (unaudited) A[pounds sterling]'000 ... unaudited) (unaudited) (unaudited) A[pounds sterling]'000 ... unaudited) (unaudited) (unaudited) A[pounds sterling]'000 ...
|
|